- Report
- October 2024
- 186 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 144 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- March 2025
- 194 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- August 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- August 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- March 2025
- 175 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- February 2024
- 118 Pages
Global
From €4991EUR$5,250USD£4,193GBP
- Report
- February 2024
- 119 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- March 2023
- 185 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- December 2021
- 209 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- February 2024
- 140 Pages
Global
From €4724EUR$4,969USD£3,968GBP
- Report
- May 2023
- 147 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- March 2025
- 50 Pages
Global
From €2519EUR$2,650USD£2,116GBP
- Book
- July 2024
- 288 Pages
Thallium-201 (Tl-201) is a radioactive isotope used in nuclear medicine and radiopharmacology. It is used in myocardial perfusion imaging, which is a type of imaging used to diagnose coronary artery disease. Tl-201 is also used in the diagnosis of tumors, and in the evaluation of cardiac function. It is produced in nuclear reactors, and is available in a variety of forms, including capsules, solutions, and kits.
Tl-201 is a relatively short-lived isotope, with a half-life of 73.1 hours. This means that it must be used quickly after production, and must be stored and handled carefully. It is also relatively expensive, due to the cost of production and the short shelf-life.
Companies in the Tl-201 market include GE Healthcare, Mallinckrodt Pharmaceuticals, Lantheus Medical Imaging, and Bracco Diagnostics. Show Less Read more
